PMOS, the new name for PCOS, reframes stubborn acne as a whole-body hormone issue. Polyendocrine metabolic ovarian syndrome (PMOS) signals that breakouts can reflect excess male-type hormones and metabolism. Your diagnosis still stands, and early acne care still follows standard skin treatment. The name change matters most when acne persists with cycle changes, unwanted hair growth, or thinning hair.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why PCOS became PMOS
- How excess hormones drive acne
- When acne warrants a closer look
- What helps PMOS-related acne
Why PCOS became PMOS
On 12 May 2026, an international consensus in The Lancet renamed polycystic ovary syndrome as polyendocrine metabolic ovarian syndrome. The Dr Sarafis Fertility clinic summary says the process took 14 years and involved 56 groups and more than 14,000 respondents. The Inito fertility-hormone company explainer describes PMOS as whole-body disease involving multiple hormone systems and metabolism.
The old name misled because it suggested ovarian cysts defined the condition. The same Dr Sarafis Fertility clinic summary notes adult Rotterdam criteria still require 2 of 3 features. An existing PCOS diagnosis remains valid during a three-year transition to full guideline use in 2028.
How excess hormones drive acne
Excess androgens drive acne by raising sebaceous-gland activity and sebum. Androgens are male-type hormones that all women make in small amounts. The Androgen Excess and PCOS Society committee report estimates adult acne is about 1.6-fold more common with PCOS.
It puts prevalence at 30 to 40 percent of women with PCOS, with 43 percent versus 21 percent of controls in a 60-study meta-analysis. That link explains why persistent adult breakouts may need hormone review, not stronger scrubs alone. It does not mean every breakout signals PMOS.
When acne warrants a closer look
PMOS affects about 170 million women worldwide, about 1 in 8, the Dr Sarafis Fertility clinic summary reports. The generally estimated range is 6 to 21 percent of reproductive-age women. The SkinTherapy Letter dermatology review and the 2013 Endocrine Society guideline warn that acne alone is a prevalent but unreliable marker of biochemical hyperandrogenism.
That term means excess male-type hormones in blood, and teens often have common, transient pubertal acne. So acne alone should not define hyperandrogenism or PCOS. Seek evaluation when persistent acne comes with other signs:.
- irregular periods
- unwanted facial or body hair growth, called hirsutism
- scalp thinning
What helps PMOS-related acne
The Endocrine Society Clinical Practice Guideline recommends the pill, patch, or vaginal ring as first-line for menstrual abnormalities plus hirsutism or acne. These methods help because they treat cycle and skin signs at the same time. PMOS-related acne needs combined skin plus metabolic care.
That includes standard acne therapy and lifestyle steps, with metformin for insulin resistance where indicated. Insulin resistance means cells respond poorly to insulin. When oral contraceptives are unsuitable, the BioMed Research International study found oral isotretinoin improved acne, free testosterone, and hirsutism scores. It also raised triglycerides and cholesterol, so ask for lipid checks before and during treatment.